Amanta Healthcar

34
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
94.90
-0.7 (-0.73%)
BSENSE

Mar 23

BSE+NSE Vol: 2.63 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -2.01% vs 8.19% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 3.79% vs 9.01% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -16.92% vs -4.63% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 189.02% vs 272.14% in Mar 2024

Compare Profit and Loss Results of Amanta Healthcar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
274.00
368.00
-94.00
-25.54%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
34.00
-34.00
-100.00%
Net Sales
274.00
333.00
-59.00
-17.72%
Expenditure (Ex Depriciation)
Stock Adjustments
-19.00
4.00
-23.00
-575.00%
Raw Materials Consumed
113.00
164.00
-51.00
-31.10%
Power & Fuel Cost
22.00
27.00
-5.00
-18.52%
Employee Cost
36.00
45.00
-9.00
-20.00%
Operating Expenses
23.00
28.00
-5.00
-17.86%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
4.00
20.00
500.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
7.00
-3.00
-42.86%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
215.00
289.00
-74.00
-25.61%
Operating Profit (PBDIT) excl Other Income
59.00
44.00
15.00
34.09%
Other Income
1.00
3.00
-2.00
-66.67%
Operating Profit (PBDIT)
61.00
48.00
13.00
27.08%
Interest
27.00
7.00
20.00
285.71%
Profit before Depriciation and Tax
33.00
40.00
-7.00
-17.50%
Depreciation
18.00
10.00
8.00
80.00%
Profit Before Taxation & Exceptional Items
14.00
30.00
-16.00
-53.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
30.00
-16.00
-53.33%
Provision for Tax
4.00
8.00
-4.00
-50.00%
Profit After Tax
10.00
21.00
-11.00
-52.38%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
101.00
-85.00
-84.16%
Profit Available for appropriations
26.00
122.00
-96.00
-78.69%
Appropriations
26.00
122.00
-96.00
-78.69%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
3.71
70.69
-66.98
-94.75%
Profit And Loss - Net Sales
Net Sales 274.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.01% vs 8.19% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.79% vs 9.01% in Mar 2024

Profit And Loss - Interest
Interest 27.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -16.92% vs -4.63% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 189.02% vs 272.14% in Mar 2024